Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
Atara Biotherapeutics | 10-Q: Q3 2024 Earnings Report
Atara Biotherapeutics | 10-Q: Q2 2024 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
Atara Biotherapeutics | 10-Q: Q1 2024 Earnings Report
Atara Biotherapeutics | 10-K: FY2023 Annual Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
Atara Biotherapeutics | 10-Q: Q3 2023 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Expanded Global Tab-cel ® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results
Atara Biotherapeutics | 10-Q: Q2 2023 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress
Atara Biotherapeutics | 10-Q: Q1 2023 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress
Atara Biotherapeutics | 10-K: FY2022 Annual Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Operational Progress
Atara Biotherapeutics | 10-Q: Q3 2022 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress
Atara Biotherapeutics | 10-Q: Q2 2022 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update